Cargando…

Using proteomimetics to switch angiogenic signaling

Detalles Bibliográficos
Autores principales:	Teng, Peng, Cai, Jianfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069461/ https://www.ncbi.nlm.nih.gov/pubmed/35530131 http://dx.doi.org/10.1016/j.apsb.2022.01.016

Ejemplares similares

Proteomimetic surface fragments distinguish targets by function
por: Tököli, Attila, et al.
Publicado: (2020)

Thrombospondin-1 proteomimetic polymers exhibit anti-angiogenic activity in a neovascular age-related macular degeneration mouse model
por: Choi, Wonmin, et al.
Publicado: (2023)

Stereocontrolled protein surface recognition using chiral oligoamide proteomimetic foldamers
por: Azzarito, Valeria, et al.
Publicado: (2015)

Covalent Proteomimetic Inhibitor of the Bacterial FtsQB Divisome Complex
por: Paulussen, Felix M., et al.
Publicado: (2022)

Selective and Potent Proteomimetic Inhibitors of Intracellular Protein–Protein Interactions**
por: Barnard, Anna, et al.
Publicado: (2015)

Selective and Potent Proteomimetic Inhibitors of Intracellular Protein–Protein Interactions
por: Barnard, Anna, et al.
Publicado: (2015)

Origin of Proteolytic Stability of Peptide-Brush Polymers as Globular Proteomimetics
por: Sun, Hao, et al.
Publicado: (2021)

Proteomimetics of Natural Regulators of JAK–STAT Pathway: Novel Therapeutic Perspectives
por: La Manna, Sara, et al.
Publicado: (2022)

Synthesis of New Proteomimetic Quinazolinone Alkaloids and Evaluation of Their Neuroprotective and Antitumor Effects
por: Long, Solida, et al.
Publicado: (2019)

A catalytic protein–proteomimetic complex: using aromatic oligoamide foldamers as activators of RNase S
por: Hegedus, Zsofia, et al.
Publicado: (2019)

Oligobenzamide proteomimetic inhibitors of the p53–hDM2 protein–protein interaction
por: Plante, Jeffrey P., et al.
Publicado: (2009)

Synthesis of highly functionalized oligobenzamide proteomimetic foldamers by late stage introduction of sensitive groups
por: Burslem, George M., et al.
Publicado: (2016)

A dimeric proteomimetic prevents SARS-CoV-2 infection by dimerizing the spike protein
por: Khatri, Bhavesh, et al.
Publicado: (2022)

Small-Molecule Proteomimetic Inhibitors of the HIF-1α–p300 Protein–Protein Interaction
por: Burslem, George M, et al.
Publicado: (2014)

The promise of anti-angiogenic cancer therapy
por: Oehler, M K, et al.
Publicado: (2000)

Commentary: What switch, to switch or not to switch: That is the question!
por: Kavarana, Minoo N.
Publicado: (2020)

Imatinib may be ABL to improve anti-angiogenic therapy
por: Raimondi, Claudio, et al.
Publicado: (2015)

Commentary: Understanding angiogenic factors in pathogenesis of persistent fetal vasculature
por: Khokhar, Sudarshan, et al.
Publicado: (2019)

Hypoxia-Inducible Factor as an Angiogenic Master Switch
por: Hashimoto, Takuya, et al.
Publicado: (2015)

Structured myeloid cells and anti-angiogenic therapy in alveolar soft part sarcoma
por: Castelli, Chiara, et al.
Publicado: (2013)

Revisiting anti-angiogenic therapy for recurrent glioblastoma
por: Peters, Katherine B.
Publicado: (2019)

S1P-S1PR1 signaling switch: a new paradigm of tyrosine phosphorylation
por: Banday, Zeeshan Z.
Publicado: (2022)

Molecular switches in signaling networks as a mechanism of action for oncogenic mutations in proximity of tyrosine residues
por: Emdal, Kristina B., et al.
Publicado: (2019)

The inhibition of protein translation promotes tumor angiogenic switch
por: Luo, Hui, et al.
Publicado: (2022)

The “Angiogenic Switch” and Functional Resources in Cyclic Sports Athletes
por: Balberova, Olga V., et al.
Publicado: (2021)

Deregulation of the circadian clock machinery: A novel biomarker for anti-angiogenic drug resistance in colorectal cancer
por: Della-Morte, David
Publicado: (2019)

Angiogenic signaling pathways and anti-angiogenic therapy for cancer
por: Liu, Zhen-Ling, et al.
Publicado: (2023)

Commentary on strategies for switching antipsychotics
por: Davis, John M, et al.
Publicado: (2008)

Towards “bionic” proteins: replacement of continuous sequences from HIF-1α with proteomimetics to create functional p300 binding HIF-1α mimics
por: Burslem, George M., et al.
Publicado: (2016)

Evolution of Proliferation and the Angiogenic Switch in Tumors with High Clonal Diversity
por: Bickel, Scott T., et al.
Publicado: (2014)

Switching to Biobased Products – The Brand Owner Perspective
por: Gaffey, James, et al.
Publicado: (2021)

LncRNAs and the Angiogenic Switch in Cancer: Clinical Significance and Therapeutic Opportunities
por: Mabeta, Peace, et al.
Publicado: (2022)

Angiogenic switch occurs late in squamous cell carcinomas of human skin
por: Strieth, S, et al.
Publicado: (2000)

Dual Switch Mechanism of Erythropoietin as an Antiapoptotic and Pro-Angiogenic Determinant in the Retina
por: Samson, Faith Pwaniyibo, et al.
Publicado: (2020)

Dynamic regulation of tumour progression by phenotype‐switching drivers
por: Vock, Laurenz, et al.
Publicado: (2022)

Fixing DNA breaks during class switch recombination
por: Jolly, Christopher J., et al.
Publicado: (2008)

Thymic stromal lymphopoietin: master switch for allergic inflammation
por: Liu, Yong-Jun
Publicado: (2006)

From opto- to radio-genetics: A switch in the wavelength
por: Proft, Juliane, et al.
Publicado: (2012)

Osteoglycin – A switch from angiogenesis to T-cell recruitment?
por: Dimberg, Anna
Publicado: (2018)

Commentary: Arterial switch operation: It's the little things that count
por: Burkhart, Harold M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hmnfokt24ghce7k72buvcdpi0n